Elidah today announced FDA clearance of Elitone for Men, a non-invasive, at-home treatment designed to help men regain ...
Bedrock Bioscience announced the Gazelle™ Chair, an advanced, non-invasive treatment designed to help patients regain control ...
Bladder control issues affect millions of people worldwide, impacting daily activities and quality of life. While common, these conditions remain treatable through various medical interventions, ...
I started future-proofing in my mid-40s. I knew menopause was coming, and I needed some way to have the upper hand—to pretend I had control over the inevitable outcome of aging in a female body. It ...
Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...
Structured behavioral therapy focused on pelvic floor muscle exercise was noninferior to treatment with solifenacin for alleviating overactive bladder symptoms in patients with Parkinson’s disease (PD ...
Add Yahoo as a preferred source to see more of our stories on Google. Urinary incontinence, or a loss of bladder control, affects up to one-third of women in the U.S. And women are twice as likely to ...
(BPT) - It was the everyday struggles that really got to Peggy Smith. Smith couldn’t even make it to the grocery store without stopping to find a bathroom, let alone enjoy activities with her family ...
You’re out running errands when the sudden urge to use the bathroom overcomes you. Unable to ignore the feeling, you begin searching for the nearest bathroom. Will you make it in time to avoid an ...
NEW YORK (Reuters Health) - Postmenopausal women who take estrogen for years are more likely to experience incontinence than those on the hormone for a shorter time or not at all, a new study finds.
Johnson & Johnson JNJ reported positive results from an early-stage study evaluating its investigational intravesical drug-releasing system with erdafitinib (Erda-iDRS) in patients with ...